Avalo Therapeutics, Inc.
$928.87M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15743.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17497.92x
$19.25Latest market snapshot
Implied fair value · at RL's multiple
$0.00100.0% below market
0.00 AVTX revenue / share×2.60x RL P/S=$0.00
Market $19.25Implied $0.00
RL · current priceP/S 2.60x
$351.24Latest market snapshot
Implied fair value · at AVTX's multiple
$2,327,653.66662,596.1% above market
133.02 RL revenue / share×17497.92x AVTX P/S=$2,327,653.66
Market $351.24Implied $2,327,653.66